The Board of Directors of BNP Paribas met on 29 July 2021. The meeting was chaired by Jean Lemierre, and the Board examined the Group’s results for the second quarter 2021.

BNP Paribas announces that it has now received all necessary approvals and completed the acquisition of 100% of Exane, thus raising its stake from the 50% previously held during a successful 17-year partnership. This milestone represents a new chapter for

The Board of Directors of BNP Paribas met on 29 April 2021. The meeting was chaired by Jean Lemierre, and the Board examined the Group’s results for the first quarter 2021.

After a successful 17-year partnership, BNP Paribas is looking to acquire up to 100% of Exane*, raising its stake from the 50% currently held.

The Board of Directors of BNP Paribas met on 4 February 2021. The meeting was chaired by Jean Lemierre and the Board examined the Group’s results for the fourth quarter and endorsed the 2020 financial statements. To read press release…

    The Board of Directors of BNP Paribas met on 4 February 2021, chaired by Jean Lemierre. The Board examined the Group’s results for the fourth quarter and endorsed the 2020 financial statements.

New York, January 7, 2021 BNP Paribas, a premier global bank, announces today it has appointed the Quantitative Investment Strategies group of Credit Suisse Asset Management (CSAM QIS) to serve as the allocation agent for the CSAM QIS Dynamic Multi-Factor…

To our esteemed legal colleagues: Recent events involving acts of violence against Black people have dramatically focused our attention on racial and social injustice in all of our societies. As leaders of corporate legal departments in the financial services industry,…

The Board of Directors of BNP Paribas met on November 2, 2020. The meeting was chaired by Jean Lemierre and the Board examined the Group’s results for the third quarter 2020. To read press release and global presentation: click HERE Contacts: Hacina…